Dysregulated selective translation in cancer: The pivotal functions of RNA-binding proteins and emerging therapeutic avenues
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189602
DOI: 10.1016/j.bbcan.2026.189602 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Xiao Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Chongqing University, Chongqing 400044, PR China; Department of Oncology, the Affiliated Hospital, Southwest Medical University, …. Hauptthemen laut MEDLINE: Neoplasms, RNA-Binding Proteins, Protein Biosynthesis, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 260 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Basic Science and Advanced Technology Research Program, Chongqing Natural Science Foundation.
Abstract (Originalsprache)
mRNA translation represents an essential layer of gene expression regulation, enabling rapid adaptation to external stimuli and maintenance of cellular homeostasis. Dysregulation of this process is a hallmark of cancer, exploited by malignant cells through alterations in trans-acting factors and cis-regulatory elements to rewire mRNA translation. This reprogramming preferentially translates oncoproteins over tumor-suppressors, ultimately driving tumorigenesis. Although RNA-binding proteins (RBPs) are key trans-regulators involved in almost all steps of mRNA translation, their specific roles in dictating dysregulated translation selectivity in cancer remain to be fully elucidated. Herein, we describe the multi-layered regulation of selective translation by RBPs, which are hijacked by malignant cells to decode the molecular grammars embedded in transcripts, including specific RNA structures, cis-regulatory sequence elements, and epitranscriptomic modifications. Moreover, we comprehensively summarize the pivotal role of RBP-mediated selective translation in shaping multiple malignant behaviors of cancer cells, thereby broadening our understanding of translational control during cancer progression. Therapeutically, we highlight emerging strategies to intervene in these RBP-driven reprogramming of translational circuits, providing an innovative direction for future anti-cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Chongqing University, Chongqing 400044, PR China; Department of Oncology, the Affiliated Hospital, Southwest Medical University, Luzhou 646000, PR China; Jinfeng Laboratory, Chongqing 401329, PR Chin…
- Department of Gastroenterology & Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, PR China.
- School of Medicine, Chongqing University, Chongqing 400044, PR China; Jinfeng Laboratory, Chongqing 401329, PR China.
- Jinfeng Laboratory, Chongqing 401329, PR China. Electronic address: lekoscu@163.com.
- Department of Oncology, the Affiliated Hospital, Southwest Medical University, Luzhou 646000, PR China; Jinfeng Laboratory, Chongqing 401329, PR China; Department of Gastroenterology & Chongqing Key Laboratory of Digest…
Förderung
- National Natural Science Foundation of China
- Chongqing Basic Science and Advanced Technology Research Program
- Chongqing Natural Science Foundation
- National Key Research and Development Program of China
Zitieren
APA
Hu, X., Xie, J., Li, Y., Li, K., & Wang, B. (2026). Dysregulated selective translation in cancer: The pivotal functions of RNA-binding proteins and emerging therapeutic avenues. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189602. https://doi.org/10.1016/j.bbcan.2026.189602
Vancouver
Hu X, Xie J, Li Y, Li K, Wang B. Dysregulated selective translation in cancer: The pivotal functions of RNA-binding proteins and emerging therapeutic avenues. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189602. doi:10.1016/j.bbcan.2026.189602
BibTeX
@article{Hu2026,
author = {Hu, Xiao and Xie, Jiayan and Li, Yaping and Li, Ke and Wang, Bin},
title = {Dysregulated selective translation in cancer: The pivotal functions of RNA-binding proteins and emerging therapeutic avenues},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189602},
doi = {10.1016/j.bbcan.2026.189602}
}
EUVIMED